Epstein Secrets

% 1.3% Average 9.6% 110% Median 9.0% 8.0% 32 EFTA00307427 AliphCom Common Stock Valuation (5000s) As of June 20.2011 Income Approach 2) COSTOF GOODS SOLD Cost of goods sold ("COGS, for fiscal years tÁ11 through 2016 were estimated based on Management's Forecast Management expects to olTer m

511,388 516,110 517,399 518,616 519,733 Full.year caprx ar % of rnwnme 3.4% 1.4% 1.4% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Remonahlenem Cheek Guideline Company Indications 0.6% to 8.7% A•crap: 2.9% Median 2.2% 35 EFTA00307430 F: F. ge"liAiAri 0000,AZA4g 00,0, 20.122q4 _zn„

% 1.3% Average 9.6% 110% Median 9.0% 8.0% 32 EFTA00307326 AliphCom Common Stock Valuation (5000s) As of June 20.2011 Income Approach 2) COSTOF GOODS SOLD Cost of goods sold ("COGS, for fiscal years tÁ11 through 2016 were estimated based on Management's Forecast Management expects to olTer m

511,388 516,110 517,399 518,616 519,733 Full.year caprx ar % of rnwnme 3.4% 1.4% 1.4% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Remonahlenem Cheek Guideline Company Indications 0.6% to 8.7% A•crap: 2.9% Median 2.2% 35 EFTA00307329 F: F. ge"liAiAri 0000,AZA4g 00,0, 20.122q4 _zn„

% 1.3% Average 9.6% 110% Median 9.0% 8.0% 32 EFTA00307225 AliphCom Common Stock Valuation (5000s) As of June 20.2011 Income Approach 2) COSTOF GOODS SOLD Cost of goods sold ("COGS, for fiscal years tÁ11 through 2016 were estimated based on Management's Forecast Management expects to olTer m

511,388 516,110 517,399 518,616 519,733 Full.year caprx ar % of rnwnme 3.4% 1.4% 1.4% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Remonahlenem Cheek Guideline Company Indications 0.6% to 8.7% A•crap: 2.9% Median 2.2% 35 EFTA00307228 F: F. ge"liAiAri 0000,AZA4g 00,0, 20.122q4 _zn„